A detailed history of Clear Harbor Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 52,381 shares of ABT stock, worth $6.07 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
52,381
Previous 50,776 3.16%
Holding current value
$6.07 Million
Previous $5.28 Million 13.17%
% of portfolio
0.49%
Previous 0.46%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$100.07 - $118.13 $160,612 - $189,598
1,605 Added 3.16%
52,381 $5.97 Million
Q2 2024

Jul 17, 2024

BUY
$100.73 - $112.44 $453,285 - $505,980
4,500 Added 9.72%
50,776 $5.28 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $29,570 - $32,659
-270 Reduced 0.58%
46,276 $5.26 Million
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $338,302 - $414,110
3,751 Added 8.77%
46,546 $5.12 Million
Q3 2023

Oct 26, 2023

SELL
$95.53 - $114.62 $56,840 - $68,198
-595 Reduced 1.37%
42,795 $4.14 Million
Q2 2023

Jul 21, 2023

BUY
$100.78 - $112.29 $648,317 - $722,361
6,433 Added 17.41%
43,390 $4.73 Million
Q1 2023

May 04, 2023

BUY
$96.86 - $114.01 $1.95 Million - $2.3 Million
20,150 Added 119.89%
36,957 $3.74 Million
Q4 2022

Jan 20, 2023

SELL
$95.06 - $111.52 $9,506 - $11,152
-100 Reduced 0.59%
16,807 $0
Q3 2022

Oct 24, 2022

SELL
$96.76 - $112.03 $10,740 - $12,435
-111 Reduced 0.65%
16,907 $1.64 Million
Q2 2022

Jul 20, 2022

BUY
$102.07 - $123.37 $4,184 - $5,058
41 Added 0.24%
17,018 $1.85 Million
Q1 2022

May 10, 2022

SELL
$114.02 - $139.04 $41,047 - $50,054
-360 Reduced 2.08%
16,977 $2.01 Million
Q4 2021

Jan 21, 2022

SELL
$115.53 - $141.46 $13,863 - $16,975
-120 Reduced 0.69%
17,337 $2.44 Million
Q3 2021

Nov 03, 2021

BUY
$116.66 - $129.06 $12,015 - $13,293
103 Added 0.59%
17,457 $2.06 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $208,617 - $245,573
1,972 Added 12.82%
17,354 $2.01 Million
Q1 2021

Apr 14, 2021

BUY
$108.84 - $128.23 $5,006 - $5,898
46 Added 0.3%
15,382 $1.84 Million
Q4 2020

Feb 04, 2021

BUY
$105.0 - $114.42 $2,940 - $3,203
28 Added 0.18%
15,336 $1.68 Million
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $49,387 - $63,210
645 Added 4.4%
15,308 $1.4 Million
Q1 2020

May 08, 2020

BUY
$62.82 - $91.86 $77,142 - $112,804
1,228 Added 9.14%
14,663 $1.16 Million
Q4 2019

Jan 29, 2020

BUY
$78.51 - $87.4 $196,275 - $218,500
2,500 Added 22.86%
13,435 $1.17 Million
Q3 2019

Oct 31, 2019

BUY
$81.84 - $88.74 $165,562 - $179,521
2,023 Added 22.7%
10,935 $915,000
Q4 2018

Feb 11, 2019

BUY
$65.56 - $74.27 $2,425 - $2,747
37 Added 0.42%
8,912 $645,000
Q4 2017

Jan 23, 2018

SELL
$53.68 - $57.47 $9,125 - $9,769
-170 Reduced 1.88%
8,875 $506,000
Q3 2017

Oct 25, 2017

BUY
$48.06 - $53.64 $434,702 - $485,173
9,045
9,045 $483,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.